New Key Statistics Module, Z-Score and F-Score
NAS:SPRO Key Ratios
| Market Cap $ M | 70.81 |
| Enterprise Value $ M | 11.13 |
| P/E(ttm) | 3.85 |
| PE Ratio without NRI | 3.12 |
| Forward PE Ratio | -- |
| Price/Book | 0.88 |
| Price/Sales | 0.67 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 105.00 |
| EPS (TTM) $ | 0.34 |
| Beneish M-Score | 11.02 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.62 |
| EV-to-EBITDA | 0.61 |
| PEG | -- |
| Shares Outstanding M | 54.05 |
| Net Margin (%) | 16.56 |
| Operating Margin % | 19.79 |
| Pre-tax Margin (%) | 19.02 |
| Quick Ratio | 2.68 |
| Current Ratio | 2.68 |
| ROA % (ttm) | 12.36 |
| ROE % (ttm) | 22.26 |
| ROIC % (ttm) | 31.42 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.58 |
SPRO Number of Guru Trades
SPRO Volume of Guru Trades
Gurus Latest Trades with NAS:SPRO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SPRO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Spero Therapeutics Inc Insider Transactions
No Available Data
News about NAS:SPRO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers